DrugPatentWatch Database Preview
Tolmar Therap Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for TOLMAR THERAP, and when can generic versions of TOLMAR THERAP drugs launch?
TOLMAR THERAP has four approved drugs.
There are five US patents protecting TOLMAR THERAP drugs.
There are sixty-eight patent family members on TOLMAR THERAP drugs in twenty-six countries.
Summary for Tolmar Therap
| International Patents: | 68 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 4 |
Drugs and US Patents for Tolmar Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 6,626,870 | Start Trial | Y | Start Trial | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | 8,470,359 | Start Trial | Y | Y | Start Trial | ||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 8,840,916 | Start Trial | Y | Start Trial | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | 8,840,916 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Tolmar Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 8,486,455 | Start Trial |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 4,938,763 | Start Trial |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,599,552 | Start Trial |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 6,773,714 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Tolmar Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2158900 | Start Trial |
| Denmark | 1322286 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0024374 | Start Trial |
| Canada | 2404194 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
